doi: 10.1186/s40360-024-00820-z 60
and deepening mechanistic investigations to clarify direct mechanisms of incretin receptor signalling in fibroblasts and immune cells across different tissue types
This guide covers the pharmacology, the clinical trial data, the side effects, the costs, and the practical considerations that should inform your conversation with a healthcare provider
A previous study of liraglutide on mice fed a diet lacking methionine and choline also found that GLP-1RAs not only could improve IR, but also reduce harmful ceramide/nerve sheath types, and reduce NAFLD inflammation and fibrosis (191)
Kenny, 2011a, 2011b
FDA-approved since 2005, GLP-1 agonists, including exenatide and newer formulations, have shown promise in improving glycemic control and aiding in sustained weight management (7)